Skip to main content
. Author manuscript; available in PMC: 2017 Nov 7.
Published in final edited form as: Dig Dis Sci. 2016 May 23;61(7):2087–2093. doi: 10.1007/s10620-016-4199-x

Table 1.

Demographic and clinical characteristics among 5,772 CHeCS hepatitis C viremic patients

Variables Overall n (%)
Total 5722
Birth year
 1965 through 1984 1037 (18.0)
 1955 through 1964 1978 (34.3)
 1945 through 1954 2267 (39.3)
 ≤1944 490 (8.5)
Male 3252 (56.3)
Race
 Non-Hispanic White 3549 (61.5)
 Non-Hispanic Black 1484 (25.7)
 Other 739 (12.8)
Median Yearly Household Income
 <30,000 1320 (22.9)
 ≥30,000 and <50,000 2663 (46.1)
 ≥50,000 and <75,000 1313 (22.7)
 ≥75,000 347 (6.0)
 Unknown 129 (2.2)
Insurance
 Medicaid only 722 (12.5)
 Medicare or Medicare plus 1373 (23.8)
 Private 3339 (57.8)
 No insurance 247 (4.3)
 Unknown 91 (1.6)
Genotype
 1a 1905 (33.0)
 2,3,5,6 823 (14.3)
 Other or unknown 3044 (52.7)
Ever received HCV treatment 2082 (36.1)
Fib4 in groups*
 <1.6 2517 (43.6)
 ≥1.6 and <2.5 1329 (23.0)
 ≥2.5 and <3.25 558 (9.7)
 ≥3.25 and ≤5.88 761 (13.2)
 >5.88 607 (10.5)
Hypertension 2448 (42.4)
Diabetes 1463 (25.3)
Cryoglobulinemia 50 (0.9)
Vasculitis 13 (0.2)
Nephrotic syndrome 19 (0.3)
Chronic kidney disease 319 (5.5)
Dialysis 25 (0.4)
eGFR*
 <30 133 (2.3)
 30–80 1788 (31.2)
 >80 3851 (67.3)
*

Renal function categorized by latest estimated glomerular filtration rate ([eGFR] measured in ml/min/1.73m2 [21,26]) during the period 2006–2013; all observation including eGFR censored at 30 days prior to the first receipt of dialysis